 |
|
|
| |
Bictegravir/Lenacapavir: Baseline and Week 48 Resistance in the ARTISTRY-2 Trial
|
| |
| |
Glasgow 2026 Nov 8-11
Michelle L D'Antoni1, Kristen Andreatta1, Cameron Soulette1, Priyanka Arora1, Eric G Meissner2, Kwad Mponponsuo1, Peter Sklar1, Nicolas Margot1, Christian Callebaut1
1Gilead Sciences, Inc., Foster City, CA, USA; 2Medical University of South Carolina, Charleston, SC, USA
|
| |
|
|
|
|
|
